New Delhi, Nov. 12 -- Pharma stocks have emerged as the star performers of Dalal Street over the past few months, especially the companies in the Contract Development and Manufacturing Organisation (CDMO) space. Laurus Labs, Gland Pharma, Piramal Pharma, and Divi's Laboratories are some of the key pharma stocks in the space which have delivered up to 90% return over the past six months.

Most of these pharma stocks have continued to rally over the past few days amid optimism around their second quarter results for the financial year 2026-27. So let's take a look at the spectacular six-month return by Laurus Labs, Gland Pharma, Piramal Pharma and Divi's Laboratories and their target prices.

Laurus Labs has emerged as the outstanding perfo...